John Paulson’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

John Paulson’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,000,000	Closed	-$8.92M	–	57
2017 Q4	$8.92M	Sell	4,000,000 -20,062,368	-83%	-$49.9M	0.17%	48
2017 Q3	$69.8M	Sell	24,062,368 -26,287	-0.1%	-$89.7K	1.25%	19
2017 Q2	$107M	Hold	24,088,655	–	–	1.45%	19
2017 Q1	$112M	Hold	24,088,655	–	–	1.49%	19
2016 Q4	$147M	Sell	24,088,655 -140,000	-0.6%	-$732K	1.85%	13
2016 Q3	$134M	Sell	24,228,655 -3,528,013	-13%	-$16.5M	1.45%	17
2016 Q2	$105M	Buy	27,756,668 +16,666,668	+150%	+$56.5M	1.07%	22
2016 Q1	$30.6M	Buy	11,090,000 +2,090,000	+23%	+$7.57M	0.23%	47
2015 Q4	$51M	Hold	9,000,000	–	–	0.31%	35
2015 Q3	$47.7M	Buy	9,000,000 +3,218,500	+56%	+$24.9M	0.25%	45
2015 Q2	$48M	Buy	5,781,500 +3,685,900	+176%	+$17.9M	0.22%	45
2015 Q1	$9.68M	Buy	+2,095,600	New	+$6.81M	0.05%	52

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

John Paulson's SGYP Position: Q1 2018 in Review

John Paulson sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 4,000,000 shares — an estimated $8.92M sold.

John Paulson first reported a position in SGYP in Q1 2015 and held it in 12 quarters. The position peaked at $147M in Q4 2016. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

John Paulson reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
John Paulson sold 4,000,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $8.92M.
John Paulson first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and held it in 12 quarters.
John Paulson's Synergy Pharmaceuticals, Inc Common Stock position peaked at $147M in Q4 2016.
147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Paulson & Co's 13F filing for Q1 2018, filed 15 May 2018.